Sudeep Pharma IPO News Today, Nov 21: Grey Market Premium Sparks High Interest

Sudeep Pharma’s IPO is launching today in India, drawing notable attention from investors. With a grey market premium (GMP) of 21.92%, this IPO is catching the eye of market participants seeking profitable listing gains. Recent successful IPOs have fueled keen interest, making this a focal point for both new and seasoned investors. Understanding the implications of the GMP and the market sentiment is crucial for making informed investment decisions in this case.